Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.

Barone, Martina; Ricci, Francesca; Sollazzo, Daria; Ottaviani, Emanuela; Romano, Marco; Auteri, Giuseppe; Bartoletti, Daniela; Reggiani, Maria LB; Vianelli, Nicola; Tazzari, Pier L; Cavo, Michele; Forte, Dorian; Palandri, Francesca; Catani, Lucia

View / Open Files

Accepted version (PDF, 408Kb)

Supporting information (PDF, 572Kb)

Authors

Barone, Martina

Ricci, Francesca

Sollazzo, Daria

Ottaviani, Emanuela

Romano, Marco

Auteri, Giuseppe

Bartoletti, Daniela

Publication Date

2019-06

Journal Title

Br J Haematol

ISSN

0007-1048

Publisher

Wiley

Volume

185

Issue

Pages

987-991

Language

eng

Type

Article

This Version

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Barone, M., Ricci, F., Sollazzo, D., Ottaviani, E., Romano, M., Auteri, G., Bartoletti, D., et al. (2019). Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.. Br J Haematol, 185 (5), 987-991. https://doi.org/10.1111/bjh.15682

Keywords

Blood Platelets, Megakaryocytes, Humans, Pyrazoles, Female, Male, Janus Kinases, Primary Myelofibrosis

Sponsorship

Italian Association for Cancer Research (AIRC) (Fellowship Rif. 20930)

Medical Research Council (MC_PC_12009)

Identifiers

External DOI: https://doi.org/10.1111/bjh.15682

This record's URL: https://www.repository.cam.ac.uk/handle/1810/292422

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.